August 12, 2022
Ono Pharmaceutical’s PD-1 inhibitor Opdivo (nivolumab) reeled in the largest sales in the Japan pharma market in July, extending its title-winning streak to seven months, according to a monthly snapshot report released by Encise. Opdivo chalked up sales of 12.9...read more